Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm

TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw

(2018) Carolina Cavalieri Gomes et al.   Nature Communications

The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma

(2016) M Fernanda Amary et al.   HISTOPATHOLOGY

The Conundrum of Genetic “Drivers” in Benign Conditions

(2016) Shumei Kato et al.   JNCI-Journal of the National Cancer Institute

The Conundrum of Genetic “Drivers” in Benign Conditions

(2016) Shumei Kato et al.   JNCI-Journal of the National Cancer Institute

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

(2013) Sam Behjati et al.   NATURE GENETICS

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

(2011) Twinkal C Pansuriya et al.   NATURE GENETICS

A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes

(2009) K. B. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD33+ CD14− Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone

(2008) Ramses G Forsyth et al.   JOURNAL OF BONE AND MINERAL RESEARCH